Pulmonary Fibrosis_Interstitial Lung Disease

Gene: ACD

Green List (high evidence)

ACD (ACD, shelterin complex subunit and telomerase recruitment factor)
EnsemblGeneIds (GRCh38): ENSG00000102977
EnsemblGeneIds (GRCh37): ENSG00000102977
OMIM: 609377, ClinGen, DECIPHER
ACD is in 4 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID 38176734 adds four unrelated families (two AD adult‑onset pulmonary fibrosis, one AR dyskeratosis congenita, one AR Hoyeraal‑Hreidarsson syndrome) with detailed clinical phenotyping and loss‑of‑function functional assays (TRAP/ddTRAP, co‑IP) confirming pathogenicity of ACD variants. Combined with the three unrelated AD families reported in PMID 31515401, the total evidence now comprises ≥5 unrelated families.
Created: 19 Dec 2025, 5:24 p.m. | Last Modified: 19 Dec 2025, 5:24 p.m.
Panel Version: 0.202

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
pulmonary fibrosis and/or bone marrow failure, telomere-related MONDO:0000148

Publications

Bryony Thompson (Royal Melbourne Hospital)

I don't know

3 probands reported with heterozygous variants (only 2 of the variants including p.Lys170 look to possibly relevant)
PMID: 31515401 - proband 1 with bone marrow failure and pulmonary fibrosis in the context of a telomere syndrome heterozygous for recurrent p.Lys170del. Proband 2 with idiopathic pulmonary fibrosis heterozygous for p.Lys170Glu. Proband 3 with idiopathic pulmonary fibrosis heterozygous for p.Ala72Glu (9 hets in gnomAD - VUS), which was also found in the unaffected 83 yo father. All patients had a leukocyte telomere length <1st percentiles for age.
PMID: 27807141 - in vitro functional assays suggesting that the recurrent variant p.Lys170del is sufficient to cause the cellular underpinnings of dyskeratosis congenita, acting in a dosage-dependent mechanism rather than dominant-negative.
PMID: 25205116 - Lys170del identified in 18-yo proband, mother, and maternal grandmother presented with bone marrow failure of varying severity, and decreasing ages of presentation in successive generations. All with short telomeres. In vitro assays demonstrate the variant localises to telomeres but fails to recruit telomerase to telomeres.
Sources: Literature
Created: 4 May 2023, 6:29 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
pulmonary fibrosis and/or bone marrow failure, telomere-related MONDO:0000148

Publications

Mode of pathogenicity
Other

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Literature
Phenotypes
  • pulmonary fibrosis and/or bone marrow failure, telomere-related MONDO:0000148
OMIM
609377
ClinGen
ACD
DECIPHER
ACD
Clinvar variants
Variants in ACD
Penetrance
None
Publications
Panels with this gene

History Filter Activity

19 Dec 2025, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ACD were set to 31515401; 27807141; 25205116

19 Dec 2025, Gel status: 3

Set mode of pathogenicity

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of pathogenicity for gene: ACD was changed from Other to None

19 Dec 2025, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ACD was changed from BOTH monoallelic and biallelic, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

19 Dec 2025, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ACD was changed from BOTH monoallelic and biallelic, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

19 Dec 2025, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ACD was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

19 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: acd has been classified as Green List (High Evidence).

19 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: acd has been classified as Green List (High Evidence).

4 May 2023, Gel status: 2

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: acd has been classified as Amber List (Moderate Evidence).

4 May 2023, Gel status: 2

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: acd has been classified as Amber List (Moderate Evidence).

4 May 2023, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set mode of pathogenicity

Bryony Thompson (Royal Melbourne Hospital)

gene: ACD was added gene: ACD was added to Pulmonary Fibrosis_Interstitial Lung Disease. Sources: Literature Mode of inheritance for gene: ACD was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: ACD were set to 31515401; 27807141; 25205116 Phenotypes for gene: ACD were set to pulmonary fibrosis and/or bone marrow failure, telomere-related MONDO:0000148 Mode of pathogenicity for gene: ACD was set to Other Review for gene: ACD was set to AMBER